Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom. Br J Cancer. 2021; 124:2026-2034
Robbins H, Alcala K, Swerdlow A, et al.
A case-only study to identify genetic modifiers of breast cancer risk specifically for BRCA1 and BRCA2 mutation carriers. Nat Comms. 2021; 12:1078
Coignard J, Lush M, Beesley J, et al.
Common susceptibility loci for male breast cancer. J Natl Cancer Inst. 2021; 113:453-461
Maguire S, Perraki E, Tomczyk K, et al.
Combined associations of a polygenic risk score and classical risk factors with breast cancer risk. J Natl Cancer Inst. 2021; 113:329-337
Kapoor PM, Mavaddat N, Choudhury PP, et al.
Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women
Verdiesen RM, van der Schouw YT, van Gils CH, et al.
DNA methylation of the long intergenic noncoding RNA 299 gene in triple-negative breast cancer: results from a prospective study. Sci Rep. 2020; 10:11762
Manoochehri M, Jones M, Tomczyk K, et al.
Germline HOXB13 Mutations p.G84E and p.R217C Do Not Confer an Increased Breast Cancer Risk. Sci Rep. 2020; 10:9688.
Liu J, Prager-van der Smissen WJC, Collée JM, et al.
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nat Genet. 2020; 52:572-581
Zhang H, Ahearn TU, Lecarpentier J, et al.
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status. Genet Epidemiol. 2020; 44:442-468
Feng H, Gusev A, Pasaniuc B, et al.
Adult weight change and premenopausal breast cancer risk: a prospective pooled analysis of data from 628,463 women. Int J Cancer. 2020;147:1306-1314
Schoemaker MJ, Nichols HB, Wright LB, et al.
